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Summary
Objective: The aim of the present study was the investigation of differential gene expression in primary human articular chondrocytes (HACs)
and in cultivated cells derived from HACs.
Design: Primary human articular chondrocytes (HACs) isolated from non-arthritic human articular cartilage and monolayer cultures of HACs
were investigated by immunohistochemistry, Northern analysis, RT-PCR and cDNA arrays.
Results: By immunohistochemistry we detected expression of collagen II, protein S-100, chondroitin-4-sulphate and vimentin in freshly
isolated HACs. Cultivated HACs, however, showed only collagen I and vimentin expression. These data were corroborated by the results of
Northern analysis using specifc cDNA probes for collagens I, II and III and chondromodulin, respectively, demonstrating collagen II and
chondromodulin expression in primary HACs but not in cultivated cells. Hybridization of mRNA from primary HACs and cultivated cells to
cDNA arrays revealed additional transcriptional changes associated with dedifferentiation during propagation of chondrocytes in vitro. We
found a more complex hybridization pattern for primary HACs than for cultivated cells. Of the genes expressed in primary HACs the early
growth response (EGR1) transcription factor showed the strongest expression whereas D-type cyclin was expressed in proliferating cells.
Other factors associated with differentiated HACs were the adhesion molecules ICAM-1 and VCAM-1, VEGF, TGF2, and the monocyte
chemotactic protein receptor.
Conclusions: Our data support the hypothesis that HACs dedifferentiate when grown in monolayer cultures. Moreover, the expression
patterns also show that proliferation and differentiation are exclusive features of human chondrocytes. © 2002 OsteoArthritis Research
Society International
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Pathologic changes of cartilage due to osteoarthritis (OA)
as well as developmental, metabolic, and inflammatory
disorders, or after trauma are an unsolved contemporary
medical problem. The intrinsic capacity of cartilage to repair
articular chondral defects is poor1,2. Unfortunately there is
also a lack of causative therapies. Consequently, biological
approaches to restore the unique mechanical com-
petence of normal articular cartilage are of major interest.
Recently, autologous chondrocyte transplantation (ACT),
first inaugurated in animal experiments by Smith and
Chesterman3, has been introduced into clinical use as a
novel biological approach4. Human articular chondrocytes
(HACs) are therefore harvested from non-affected, non-
weight-bearing areas of the same joint during arthroscopy.
HACs are subsequently grown in monolayer cell culture in
order to achieve sufficient amounts of cells to fill the
articular defect covered by a periosteal flap in a second62operation4. It has been shown previously, however, that
HACs dedifferentiate to a fibroblast-like state when culti-
vated in monolayers5. This shift in cellular differentiation
has been demonstrated both by morphological changes
and by alterations in collagen expression patterns6,7. The
extent and the reversibility of this process is actually
unknown. Consequently, the identification of the genes
involved in chondrocyte differentiation will be of major
interest in biological therapy approaches. The aim of the
present study was the identification of genes which are
differentially regulated between primary and dedifferenti-
ated HACs after cultivation in monolayers by novel cDNA
array technologies.Material and methodsReceived 26 October 2000; revision requested 11 January 2001;
revision received 13 April 2001; accepted 4 June 2001.
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Non-arthritic human articular cartilage was isolated from
femoral heads of five patients with displaced femoral neck
fractures (two male, three female, patients’ mean age was
84 years). The cartilage specimens were taken immediately
after surgery, placed into Petri dishes and moistened with
phosphate buffered saline (PBS). Two sterile scalpels were
used to dice the cartilage into 1–3 mm3 pieces. The PBS
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modified Eagle’s medium (DMEM, Life Technologies, Inc.,
Rockville, MD, U.S.A.) with 200 U/ml collagenase type II
from clostridium histolyticum (Life Technologies, Inc.,
Rockville, MD, U.S.A.). The tube was capped, covered with
Parafilm, placed sideways on an orbital shaker at 25 rpm,
and incubated at 37°C for 20 h. The following day the
digestate was resuspended, and centrifuged at 1000 rpm
for 10 min. The supernatant was removed and the pellet
gently resuspended with 10 ml calcium- and magnesium-
free PBS. The suspension was filtered through a 100 m
mesh into a sterile polypropylene tube. Cells were centri-
fuged and washed twice, then counted in a hemocytometer,
resuspended in medium, and placed into T-75-flasks at a
density of 1.5×104/cm2 and grown at 37°C and 5%CO2 as
monolayer cultures in DMEM supplemented with 10% FCS,
2 mM L-glutamine, 50 l/ml ascorbic acid.
Total RNA was isolated from primary HACs at day 7 and
at day 42 (passage 2) using the RNeasy kit (Qiagen,
Hilden, Germany) following the manufacturer’s recommen-
dations. Briefly, cells were directly lysed in culture flasks by
addition of Qiagen Buffer RLT. Subsequently, cell lysates
were collected with a rubber policeman and homogenized
by passing the lysate at least 5–10 times through an
20-gauge needle. After addition of 2.0 ml of 70% ethanol
the homogenized lysate was applied to an RNeasy spin
column placed in a 15-ml centrifuge tube and centrifuged
for 5 min at 5000×g two times. Columns were washed
twice with Buffer RW1 and in Buffer RPE for 2 min at
5000×g and subsequently eluted in 150 l of RNase-free
water for 3 min at 5000×g.NORTHERN-ANALYSIS
Total RNA was isolated from primary HACs and after two
passages of monolayer cell culture at day 42 using the
RNeasy kit (Qiagen, Hilden, Germany) following the manu-
facturer’s recommendations. For Northern analysis, 7 g oftotal RNA were separated by agarose gel electrophoresis
and subsequently transferred to nitrocellulose membranes
using standard protocols8. Hybridization was performed
using cDNA fragments radioactively labelled with
[32P]dATP (specific activity: 2×109 cpm/g) following
standard protocols8. For low expression products, RT-PCR
using specific primer pairs was performed as previously
described9.REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION
(RT-PCR)
First strand synthesis was carried out using 250 ng RNA
in a final volume of 20 l containing 50 mM Tris-HCl,
75 mM KCl, 3 mM MgCl2, 10 mM DTT, 250 M each dNTP,
0.5 l of hexanucleotide mix and 100 U M-MLV reverse
transcriptase at 37°C for 2 h. PCR was performed using
2.5 l of the first strand reaction in a 50 l reaction volume
containing 0.3 M primer (Table I), 10 mM Tris-Cl, 75 mM
KCl, 1.5 mM MgCl2, 200 M each dNTP and 1 U Taq DNA
polymerase. The reaction mixture was heated at 95°C for
5 min to denature the DNA and then subjected to 28 cycles
of PCR (94°C for 1 min, specific annealing temperature for
1 min, 72°C for 2 min) followed by a final extension at 72°C
for 5 min. The oligonucleotides used as primers (synthe-
sized by MWG-Biotech, Ebersberg, Germany) are sum-
marized in Table I. PCR products were analysed by
non-denaturing PAGE (12.5% polyacrylamide) and
visualized by silver staining as previously described10.ATLAS ARRAYS
Hybridization on Atlas cDNA expression arrays
(Clontech, Heidelberg, Germany) was performed following
the manufacturer’s recommendation with minor modifi-
cations. Briefly, 5 g total RNA were labelled by reverse
transcription using MMLV reverse transcriptase (Promega,
Madison) in a reaction buffer supplemented with DTT,
[32P]dATP (3000 Ci/mmol, 10 mCi/ml), and the Atlas CDS
Primer Mix. Subsequently, free nucleotides were separated
from labelled cDNA using Chroma Spin-200 DEPC-H20
columns. Atlas membranes were prehybridized in
ExpressHyb hybridization solution containing denatured
sheared salmon testes DNA (3%) for 30 min at 68°C.
Hybridization was performed after adding the labelled
cDNA probes (2×106 cpm) and C0t-1 DNA to the hybrid-
ization solution for 14 h at 68°C. Filters were exposed to
Kodak BioMax MR film overnight at −70°C in presence of
intensifying screens. The quantitative analysis was carried
out by phosphorimager using the Software Image Gauche
V 3.1 (Fuji).ResultsIMMUNOHISTOCHEMISTRY
HACs showed extensive morphological changes during
cultivation as monolayer cell cultures. Cytologically, freshly
isolated HACs showed a round to polygonal cell mor-
phology whereas cultivated cells exhibited an elongated
fibroblast-like phenotype (Fig. 1). By IHC we found expres-
sion of collagen II, protein S-100, chondroitin-4-sulphate
and vimentin in freshly isolated HACs. Cultivated HACs,
however, showed only collagen I and vimentin expression.
The changes in expression pattern occured around day 21IMMUNOHISTOCHEMISTRY
Morphological characterization was performed immuno-
cytochemistry using mouse monoclonal antibodies di-
rected against conformational determinants of human
collagen type I (Southern Biotechnology Associates Inc.,
Birmingham, AL, U.S.A.), directed against the carboxyl-
terminal part of the a1(II) chain of collagen type II, (clone
2B1.5, Neomakers, Union City, CA, U.S.A.), chondroitin-4-
sulphate (clone BE-123, Chemicon Int. Inc., Temecula,
CA), and vimentin (clone V9, Dako A/S, Glostrup,
Denmark). Briefly, cells grown on sterile slides were
washed in phosphate-buffered saline (PBS). Slides were
incubated with the primary antibodies diluted 1:100 in
PBS/2% bovine albumin (BSA, Sigma Chemical) for 1 h at
room temperature in a humidified chamber. Slides were
then washed three times with PBS, incubated at room
temperature in a humidified chamber for 1 h with biotin-
conjugated horse antimouse secondary antibody (Vector
Laboratories, Inc., Burlingame, CA, U.S.A.) diluted 1:100
into PBS/2% bovine albumin and subsequently treated with
avidin biotin (Vectastain ABC Kit, Vector Laboratories) for
30 min. For negative controls the first antibody was omitted.
Immunoreactivity was visualized with 3,3′-diamino-
benzidine tetrahydrochloride (DAB, final concentration
5 mg/ml in 0.05 M Tris buffer, pH 7.6, 15 min). Sections
were counterstained with Mayer’s haemalaun.
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results of Northern analysis using specifc cDNA probes
for collagens II and III and chondromodulin, respectively
(Fig. 2). By Northern analysis collagen I, however, also
showed expression in primary HACs (Fig. 2).Table I
Oligonucleotide used as primers for RT-PCR
Gene Acc no. Temp Size Ori Sequence
Collagen 1 X066269 56.8 159 Sense CCC AAG GAC AAG AGG CAT
Antisense GCA GTG GTA GGT GAT GTT CTG
Collagen 2 X 16711 57.7 225 Sense GGT CCT TCT GGA AAA GAT GG
Antisense AGG GAA TCC TCT CTC ACC AC
Collagen 3 X 15332 57.9 229 Sense GGG TCC TAC TGG TCC TAT TGG
Antisense GCC TCC TTC ACC TTT CTC AC
Chondr 4S NM001897 58.2 242 Sense CCC CCA TCC TCA CTA CAA AC
Antisense ATC CAG GGT TCC TCT GTG TG
Chondr 6S AB012192 58.1 216 Sense CCC GTC TTT CTG GCT GAA
Antisense GTT GGG TCT GGG TGT GAT G
Chond Mod AF050147 56.8 156 Sense GCT GGA GGA CTA TGA AGC ACT
Antisense GGT GGG GTT GTC AGT TAT CTC
BMP 7 NM001719 57.4 198 Sense ATG CCA TCT CCG TCC TCT AC
Antisense AGG GGA AGG TCT CAC AAA AG
BMP 8 NM001720 57.5 185 Sense AGC CGA AGA AAA GCA ACG
Antisense GTC CCC CTC ACA GTA ATA GGC
CD 44 M59040 56.6 203 Sense GGG GTC CCA TAC CAC TCA T
Antisense TTT TCT TCT GCC CAC ACC T
Cyclin D1 X59798 58.6 179 Sense GCG GAG GAG AAC AAA CA
Antisense GTG AGG CGG TAG TAG GAC A
Cyclin D3 M92287 58.8 169 Sense TTT TTG GCC CTC TGT GCT A
Antisense GCA GGC AGT CCA CTT CA
ICAM I J03132 58.4 212 Sense GAT CTT GAG GGC ACC TAC C
Antisense CCT TTT TGG GCC TGT TGT A
ICAM II X15606 58.6 183 Sense GTT CCG TGG CAA TGA GAC T
Antisense GGG GCT GAG TGT TTG TG
ICAM I R X69711 58.6 200 Sense AGC TCA CGA GGC AAA TAC A
Antisense GAC GTG AGG GGC AGA TAG
IGF I R X 04434 58.5 168 Sense ACG GGG CGA TCT CAA AAG T
Antisense CGG GCA GCA AGG TCT CTG T
IGF II R Y 00285 58.9 283 Sense CTG TTT CTT CCA CCA TCT T
Antisense TCC CTC CTC TCC TTC TT
IGF BP I M 31145 58.6 266 Sense TGC GTG CAG GAG TCT GAC
Antisense TCC TGT GCC TTG GCT AAA C
IL 2 R X 01057 58.6 168 Sense AAG CGA GCC TTC CAG GTC A
Antisense TCC CGT GGG TCA TTT TGC
EGR-1 X 52541 54.9 168 Sense TCT TCG TCC TTT TGG TTT
Antisense CCC TCT TCC TTA TTT TGC T
TGF B2 M 19154 58.6 171 Sense CCC CAG AAG ACT ATC CTG A
Antisense GCG GCA TGT CTA TTT TGT
TGF B3 J 03241 55.4 208 Sense GTG AGT GGC TGT TGA GAA
Antisense AGA TGA GGG TTG TGG TGA
TGF B1 X 02812 58.6 189 Sense AAT TCC TGG CGA TAC CTC A
Antisense GAA CCC GTT GAT GTC CAC
TNF R M 33294 58.6 155 Sense GGG GAG CTT GAA GGA AC
Antisense GCA AAG TTG GGA CAG TCA C
VCAM 1 X 53051 58.2 150 Sense CAA TGT TGC CCC CAG AG
Antisense GGC TGT AGC TCC CCG TTA G
IGF BP 3 M 35878 56.4 308 Sense TTA TGG CAC GGT TTC CTG T
Antisense CCC TCT CCC TCC CTT TCT C
BMP 2 M 22490 57.5 290 Sense TGC TTT TCG TTT CCT CTT
Antisense CAT AGT TTG GCT GCT TCT C
(Acc No.=Gene Bank Accession Number; ori=orientation; temp=annealing temperature; size=size of PCR
product.)ATLAS ARRAYS
Atlas blots exhibited complex hybridization patterns
when hybridized with cDNAs generated from RNAs ofprimary HACs and RNA of cultivated fibroblast-like
chondrocytes (Fig. 3). By densitometry, highest intensities
of hybridization signals were detected for the guanine
nucleotide-binding protein G-s alpha subunit (GNAS), for
the 60S ribosomal protein L6 (RPL6) and for the nuclease-
sensitive element DNA-binding protein (NSEP) both in
primary HACs and in cultivated cells (Table II). In addition,
the early growth response protein 1 (EGR1), also known as
KROX24 showed a very intense hybridization signal in
primary HACs but not in cultivated cells (Table III).
Osteoarthritis and Cartilage Vol. 10, No. 1 65Fig. 1. Immunocytochemistry of primary (A) and cultivated (B) HACs using monoclonal antibodies raised against collagen II revealed
expression of collagen II only in primary but not in cultivated HACs. Morphology of cells changed from a differentiated round to polygonal cell
shape (A) to an elongated fibroblast-like phenotype (B) when grown in monolayer cultures.Fig. 2. Northern blots of primary (P) and cultivated (C) HACs showed expression of collagen II and chondromodulin only in primary HACs
and collagen III only in cultivated cells. By Northern analysis collagen I expression could be detected in both cell types.There were additional quantitative and qualitative differ-
ences between these two cell types. By hybridization using
cDNAs generated from RNA of primary HACs to Atlas
arrays, 93 spots could be visualized, however, only 64
spotted cDNA clones on Atlas arrays showed hybridization
with cDNA generated from RNA of cultivated HACs. There
were also multiple differences in the signal intensities of
individual hybridization spots. Clones exhibiting more than
2.5-fold densitometric ratios between the two cell types
were regarded as possibly differentially regulated genes
(Tables III and IV). These differences were most prominentin the clones representing the genes for cyclinD1, the TNF
receptor alpha, and prothymosin alpha, which were
expressed exclusively in cultivated but not in primary
HACs, and the IGF binding protein 3, which exhibited a
3-fold up-regulation in cultivated cells (Table III).
On the other hand, the clones representing EGR1,
MCP-1RA, V-CAM1, ICAM-1, TGF2 and VEGF showed
an exclusive hybridization in primary HACs or less
than 10% of the level of primary HACs in cultivated cells
(Table III). Atlas array results were confirmed by Northern
analysis and RT-PCR (Fig. 3).
66 M. Schnabel et al.: Dedifferentiation-associated changes in morphology and gene expressionFig. 3. Atlas cDNA arrays of differentiated primary HACs (A) and dedifferentiated HACs after monolayer cultivation (B) showing multiple
qualitative and quantitative differences. Results were confirmed by RT-PCR (C), representative RT-PCR results of VCAM 1, IGF-BP3 and
-actin or by Northern analysis (D), representative Northern blots with probes of transcripts expressed in primary HACs (VEGF), in cultivated
HACs (TNFR1) or in both cell types (GAPDH), P=primary, C=cultivated.
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Genes equally (less than 2.5-fold) expressed in primary HACs and after cultivation
Name Acc no. Primary Culture X-fold
Guanine nucleotide-binding protein G-s alpha subunit (GNAS) M14631 392.23 180.17 2.2
60S ribosomal protein L6 (RPL6) X69391 370.97 150.12 2.5
Nuclease-sensitive element DNA-binding protein (NSEP) M83234 333.83 171.90 1.9
Transcription factor ATF-4; cAMP-response element binding prot. (CREB2) D90209 257.61 99.46 2.5
Defender against cell death 1 (DAD1) D15057 218.95 88.24 2.5
Mitogen-activated protein kinase p38 (MAP kinase p38) L35253 131.56 81.91 1.6
Nucleoside diphosphate kinase B (NDP kinase B; NDKB) L16785 106.13 53.13 2.0
Fos-related antigen (FRA1) X16707 82.54 31.75 2.6
Cyclin-dependent kinase inhibitor 1 (CDKN1A. CIP1. WAF1) U09579 74.84 43.33 1.7
Acyl-CoA-binding protein (ACBP); diazepam binding inhibitor (DBI) M14200 61.79 36.32 1.7
Glutathione S-transferase mu1 (GSTM1; GST1); HB subunit 4; GTH4 X68676 56.81 26.36 2.2
c-jun proto-oncogene; transcription factor AP-1 J04111 50.27 46.49 1.1
Macrophage-specific colony-stimulating factor (CSF-1; MCSF) M37435 41.92 31.22 1.3
Clusterin precursor (CLU); complement-associated protein SP-40,40 M74816 41.73 23.44 1.8
Ephrin type-A receptor 1 precursor; tyrosine-protein kinase receptor eph M18391 40.88 17.99 2.3
Glutathione S-transferase theta 1 (GSTT1) X79389 39.54 21.88 1.8
cAMP-responsive element-binding protein (CREB1) L05515 38.74 15.26 2.5
Natural killer cell enhancing factor (NKEFB) L19185 37.90 27.02 1.4
NADH-ubiquinone oxidoreductase B18 subunit M33374 37.48 17.96 2.1
CACCC-box DNA-binding protein L04282 32.25 14.23 2.3
Platelet-derived growth factor receptor alpha subunit (PDGFRA) M21574 31.80 26.13 1.2
Putative transcription activator DB1 D28118 31.57 13.28 2.4
Zinc finger X-chromosomal protein (ZFX) X59738 28.58 17.96 1.6
Growth arrest & DNA-damage-inducible protein (GADD45) M60974 28.47 22.14 1.3
Integrin beta 5 subunit precursor (ITGB5) J05633 28.43 14.88 1.9
mutL protein homolog; DNA mismatch repair protein MLH1; COCA2 U07418 28.06 16.18 1.7
40S ribosomal protein S19 (RPS19) M81757 24.39 19.95 1.2
Activator 1 37-kDa subunit; replication factor C 37-kDa subunit (RFC37) M87339 24.02 15.08 1.6
Neurotrophic tyrosine kinase receptor-related 3; TKT precursor X74764 20.14 12.83 1.6
Nuclear factor I (NFI); NFI-X L31881 19.72 8.45 2.3
Cytoplasmic dynein light chain 1 (HDLC1) U32944 19.05 16.02 1.2
Transforming growth factor beta receptor III (TGFR-III) L07594 19.00 15.51 1.2
Monocyte chemotactic protein 1 precursor (MCP1) M24545 138.09 169.92 1.2
Mitochondrial matrix protein P1 precursor; heat shock protein 60 (HSP-60) M34664 76.37 83.85 1.1
Fibronectin receptor beta subunit (FNRB);CD29 antigen X07979 75.36 81.18 1.1
Thymosin beta-10 (TMSB10; THYB10); PTMB10 M92381 33.62 82.18 2.4
Transforming protein rhoA H12 (RHO12; ARH12; ARHA) L25080 33.07 51.63 1.6
Fas-activated serine/threonine (FAST) kinase X86779 30.94 41.62 1.3
Cytosolic superoxide dismutase 1 (SOD1) K00065 23.40 23.57 1.0
Insulin-like growth factor binding protein 1 (IGFBP1) M31145 22.41 34.95 1.6
Replication factor C 38-kDa subunit (RFC38); activator 1 38-kDa subunit L07541 20.29 24.55 1.2
Keratinocyte growth factor (KGF); fibroblast growth factor 7 (FGF7) M60828 11.23 24.11 2.1
(Acc No.=Gene Bank Accession Number.)Discussion
Pathological alterations of articular cartilage represent a
major clinical problem and may occur in different circum-
stances including OA and after trauma. So far, no causative
treatment is known and the depth of sientific evidence
supporting clinically used methodes to restore articular
surfaces is limited11. The understanding of the underlying
mechanisms of proliferation and differentiation is a neces-
sary contribution to develop new biological therapies to a
better outcome of patients suffering from joint diseases.
Recently, autologous chondrocyte transplantation (ACT)
has been introduced as a novel biological treatment4. This
approach, however, is hampered by its dependence of prior
cultivation in order to increase the number of chondrocytes
for transplantation. In the present study chondrocytes
changed their morphology from a differentiated round to
polygonal cell shape to an elongated fibroblast-like pheno-
type when grown in monolayer cultures. This phenotypic
alteration was accompanied by changes in collagenexpression patterns, and most prominently monolayer cells
lose their collagen II and chondromodulin expression,
which is highly specific in chondrocytes5–7.
Thus, the prerequisite for a biological therapy using ACT
is the understanding of the differentiation/dedifferentiation
processes in chondrocytes. We therefore used a novel
cDNA array technology to identify genes which are involved
in the complex mechanisms of chondrocyte dedifferentia-
tion in monolayer cultures. The use of cDNA arrays gained
widespread acceptance for high-throughput analysis of
gene expression. The array technology is based on cDNA
fragments spotted to solid phase support, e.g. glass slides
or nylon membranes. After hybridization with mRNA the
intensity of the hybridization signal (radioactivity or fluor-
escence) depends on the quantity of mRNA molecules in
the sample. Therefore, cDNA arrays allow a comprehen-
sive analysis of gene expression by comparing the hybrid-
ization of two or more mRNA samples. The Atlas Human
cDNA Expression Array I includes 588 genes that play key
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Genes exclusively or >2.5-fold expressed in primary HACs
Name Acc no. Primary Culture X-fold
Intercellular adhesion molecule-1 precursor (ICAM1); CD54 antigen J03132 97.26 <1
Transforming growth factor beta2 precursor (TGF-beta2; TGFB2) M19154 65.71 <1
Vascular endothelial growth factor precursor (VEGF) M32977 58.85 <1
Cellular nucleic acid binding protein (CNBP) M28372 36.17 <1
CCAAT-binding transcription factor subunit B (CBF-B) M59079 32.92 <1
Tristetraproline (TTP; TIS11; ZFP36; NUP475) M92843 29.55 <1
Glutathione S-transferase pi (GSTP1; GST3) X08058 28.72 <1
Caspase-4 precursor (CASP4) U28014 28.44 <1
Alpha1 catenin (CTNNA1); cadherin-associated protein; alpha E-catenin D13866 28.37 <1
Transcription elongation factor SII M81601 27.84 <1
Heat shock 90-kDa protein A (HSP90A; HSPCA); HSP86 X07270 26.65 <1
Transcription initiation factor TFIID 31-kDa subunit; TAFII31; TAF2G U30504 26.20 <1
Dioxin-inducible cytochrome P450 1B1 (CYP1B1) U03688 23.84 <1
Growth arrest & DNA-damage-inducible protein 153 (GADD153) S40706 23.75 <1
GA-binding protein (GABP-beta2); transcription factor E4TF1-60 D13318 23.00 <1
Ini1 U04847 21.61 <1
Extracellular signal-regulated kinase 3 (ERK3); MAP kinase 3 (MAPK3) X80692 20.42 <1
DNA-binding protein TAXREB302; albumin D box-binding protein (DBP) D28468 18.08 <1
Interleukin-1 beta precursor (IL-1; IL1B); catabolin K02770 17.33 <1
Platelet-derived growth factor B subunit precursor (PDGFB; PDGF2) X02811 16.97 <1
Erythroid differentiation protein (EDF); inhibin beta A; activin beta-A J03634 16.84 <1
HHR23A; UV excision repair protein protein RAD23A D21235 16.65 <1
Insulin-like growth factor II receptor (IGFR II); mannose-6-p receptor Y00285 16.44 <1
Protein C inhibitor (PROCI; PCI) M68516 16.19 <1
Guanine nucleotide-binding protein G(I)/G(S)/G(T) beta subunit 1 (GNB1) M36430 16.17 <1
Xeroderma pigmentosum group C repair complementing protein p58 D21090 15.64 <1
Beta catenin (CTNNB) X87838 15.13 <1
CCAAT-binding transcription factor subunit B (CBF-B) M59079 15.05 <1
Glutathione S-transferase A1 (GTH1; GSTA1) M25627 13.79 <1
Guanine nucleotide-binding protein G-i/G-s/G-t beta subunit 2 M36429 13.74 <1
Related to receptor tyrosine kinase (RYK) S59184 13.68 <1
Erythrocyte urea transporter (UTE; UT1); SLC14A1; HUT11; RACH1 U35735 13.41 <1
Ski oncogene X15218 12.37 <1
Extracellular signal-regulated kinase 1 (ERK1; p44-ERK1); MAP kinase 1 X60188 10.27 <1
Neuromedin B receptor (NMBR); NMB-preferring bombesin receptor M73482 10.04 <1
Early growth response protein 1 (EGR1. KROX24. zif-268) X52541 358.30 35.74 10.03
Vascular cell adhesion protein 1 precursor (V-CAM 1); CD106 antigen M30257 158.14 12.88 12.28
Nucleobindin precursor (NUC) M96824 134.16 36.63 3.66
Monocyte chemoattractant protein 1 receptor (MCP-1RA) U03882 74.76 4.40 16.99
Transducer of erbB2 (TOB) D38305 63.39 14.94 4.24
Vascular endothelial growth factor receptor 1 (VEGFR1) X51602 37.86 10.44 3.63
R kappa B DNA-binding protein U08191 36.61 9.09 4.03Table IV
Genes exclusively or >2.5-fold expressed in proliferating fibroblast-like HACs
Name Acc no. Primary Culture X-fold
Insulin-like growth factor-binding protein 3 (IGFBP3; IBP3) M31159 44.67 125.62 0.36
G1/S-specific cyclin D1 (CCND1); cyclin PRAD1; bcl-1 oncogene X59798 <1 41.56
Tumor necrosis factor receptor 1 (TNFR1) M33294 <1 21.02
Prothymosin alpha (ProT-alpha; PTMA) M26708 <1 16.62
Ubiquitin-conjugating enzyme E2 17-kDa (UBE2A) M74524 <1 12.43
Tyrosine-protein kinase receptor UFO precursor; axl oncogene M76125 <1 9.74
cdc2-related protein kinase PISSLRE L33264 <1 7.78roles in a variety of biological processes including differ-
entiation, proliferation and apoptosis. The utility of Atlas
arrays for accurately and reproducibly assessing gene
expression is well established12,13. It is therefore particular
suitable for the screening of differential gene expression in
human chondrocytes.
Using this approach we identified multiple changes in
gene expression patterns between primary HACs and
cultivated cells after two passages of monolayer culture(42 days). In primary HACs 93 of 588 genes spotted on
Atlas arrays could be detected by autoradiography; how-
ever, in cultivated cells only 64 genes were detected. These
data indicate that the expression pattern in differentiated
primary HACs was more complex than that of dedifferenti-
ated fibroblast-like cells. Moreover, the data also indicate
that several genes are down-regulated during monolayer
propagation. Among the genes which are mainly expressed
in primary HACs is the transcription factor EGR-1 (also
Osteoarthritis and Cartilage Vol. 10, No. 1 69called KROX24 and zif-268) which belongs to the class of
immediate early genes14. EGR-1 is crucial in the regulation
of growth factors, hormones, cytokines, lipoproteins and
adhesion molecules15. It has been shown that EGR-1 is
highly expressed in fetal and human chondrocytes16. In
addition, EGR-1 expression was always detectable in
immortalized chondrocytes which exhibited signs of
differentiation, i.e. collagen II and IX expression17,18.
Recently, downregulation of EGR-1 in chondrocytes has
been attributed to osteoarthritis19. Thus, EGR-1 is con-
sidered as a differentiation specific transcription factor in
chondrocytes. EGR-1 has also been demonstrated as a
transcriptional regulator of important differentiation factors
in several tissues15. So far, however, its target genes in
chondrocyte differentiation are not established. It seems
not to be directly involved in collagen expression, since no
EGR-1 binding site has been identified in the promoter
regions of the collagen genes. Therefore, the identification
and functional analysis of target genes regulated by EGR-1
in chondrocytes could substantially attribute to the better
understanding of the molecular biology of cartilage. Other
factors exclusively expresed in primary HACs include the
genes for the adhesion molecules V-CAM1, the vascular
endothelial growth factor and the transforming growth fac-
tor 2 which have been linked to chondrocyte differentiation
in some recent reports20–23. The data of the present study
also corroborate recent results indicating a role of chemo-
kines in normal cartilage biology24,25. In addition, we found
both the monocyte chemotactic protein (MCP1, SCYA2)
and its receptor (MCP1-RA, CCR2) highly expressed in
chondrocytes. MCP1 was expressed both in primary and
fibroblast-like HACs, its receptor, however, was dramati-
cally downregulated in proliferating cells.
Among the factors which were exclusively expressed in
cultivated fibroblast-like cells cyclinD1 showed the highest
expression both on Atlas arrays and by RT-PCR. D-type
cyclins are essential factors in cell cycle regulation of
proliferating cells including chondrocytes26. Its expression
is important for cell proliferation and it is not surprising that
it could be detected in the proliferating chondrocytic cells. It
has been shown, however, that overexpression of cyclinD
in different cells types inhibits terminal differentiation of
these cells27. Thus, its expression is not only important for
proliferation but it also interferes with differentiation.
Another factor which is upreglated in proliferating cells is
the IGF binding protein 3 (IGF-BP3). IGF-BPs are import-
ant factors in insulin-like growth factor signalling15. Their
exact role is not completely understood. There are several
reports indicating a modulating effect in IGF signalling by
binding to IGF-BPs15. Therefore, its expression could con-
tribute to dedifferentiation in chondrocytes since IGF seems
to be involved in cartilage differentiation. However, the
IGF-BP1 exhibited expression both in primary and in
fibroblast-like cells.
The data presented here also support the hypothesis
that proliferation and differentiation are exclusive features
in human chondrocytes. Therefore, prior cultivation to
obtain high cell counts for ACT must result in loss of
differentiation. The understanding of the cell type specific
gene expression could open new approaches to cultivate
and redifferentiate chondrocytes for novel biological
therapies of joint diseases.
The identification of genes known to be associated with
cartilage dedifferentiation and proliferation confirms the
reliability of the Atlas Array procedure. Results obtained
by this method, however, need to be confirmed by other
methods, e.g. immunohistochemistry, Northern analysisand RT-PCR, which has also been demonstrated here.
While some of the genes presented here have been
implicated in chondrocyte biology previously, the identifi-
cation of transcripts that have not been linked to cartilage
before represents one type of novel information which can
only be obtained using screening methods like the array
technology. The wealth of sequence information made
available trough the human genome project will lead
researchers towards systemic approaches that involve the
simultaneous analysis of hundreds and thousands of
genes. Analysing chondrocytes using current cDNA array
technologies and additional arrays containing cartilage-
specific genes will allow an analysis of complex gene
expression patterns involved in chondrocyte differentiation
and may therefore help to obtain detailed functional
insights into cartilage metabolism.Acknowledgments
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